EAALX
Price
$22.20
Change
-$0.02 (-0.09%)
Updated
Nov 18 closing price
Net Assets
834.99M
GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
Interact to see
Advertisement

EAALX vs GFACX

Header iconEAALX vs GFACX Comparison
Open Charts EAALX vs GFACXBanner chart's image
Eaton Vance Atlanta Capital Focused Gr A
Price$22.20
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets834.99M
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
EAALX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
EAALX vs. GFACX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAALX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. EAALX (835M). EAALX (0.00) and GFACX (0.00) have matching dividends . EAALX was incepted earlier than GFACX: EAALX (22 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than EAALX (1.01). GFACX is a more actively managed with annual turnover of: 25.00 vs. EAALX (14.00). GFACX has a lower initial minimum investment than EAALX: GFACX (250) vs EAALX (1000). GFACX annual gain was more profitable for investors over the last year : 5.07 vs. EAALX (1.93). EAALX return over 5 years is better than : 46.28 vs. GFACX (24.08).
EAALXGFACXEAALX / GFACX
Total Expense Ratio1.011.3674%
Annual Report Gross Expense Ratio1.011.3674%
Fund Existence22 years25 years-
Gain YTD6.52014.44545%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets835M330B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.935.0738%
Returns for 3 years40.1954.8673%
Returns for 5 years46.2824.08192%
Returns for 10 years43.8269.6663%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP6.900.21
+3.13%
Fortress Biotech
TLPH1.340.02
+1.52%
Talphera
JANX29.020.30
+1.04%
Janux Therapeutics
MBAV10.580.01
+0.09%
M3 Brigade Acquisition V Corp.
CDE14.38-0.08
-0.55%
Coeur Mining